Fluvoxamine Fails to Shorten COVID-19 Symptom Duration in Mild to Moderate Outpatients
Coronavirus News
Publication date: Dec 09, 2024 Measures of activity limitation and time spent unwell were also comparable, indicating no clinically meaningful benefit of fluvoxamine in this population. However, the researchers acknowledged ... Read more